[Therapy of psoriasis vulgaris with efalizumab]

J Dtsch Dermatol Ges. 2006 Jun;4(6):511-2. doi: 10.1111/j.1610-0387.2006.05885.x.
[Article in German]
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal, Humanized
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Humans
  • Long-Term Care
  • Psoriasis / drug therapy*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • efalizumab